Market Rank #23 · Evidence Tier A

Austria
Neuroscience Intelligence

Austria neuroscience intelligence: 114 indexed trials, 68 institutions, research score 37.83.

⚗
114Indexed trials
↗
33Recruiting
⌂
68Research institutions
◎
37.8Research score

Evidence profile

73Sponsors
22Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 37.8 · Data confidence 100.00 · Evidence 37.8

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

parkinsons29trials
alzheimers14trials
epilepsy13trials
stroke10trials
depression7trials
multiple_sclerosis6trials
neuro_oncology6trials
adhd4trials
other_neurology4trials
movement_disorders3trials

Leading indexed sponsors

Merck Sharp & Dohme LLC9trials
Boehringer Ingelheim8trials
Medical University of Vienna6trials
Medical University of Graz4trials
Hoffmann-La Roche4trials
Affiris AG3trials
Novartis Pharmaceuticals3trials
JANSSEN Alzheimer Immunotherapy Research & Development, LLC2trials
Genzyme, a Sanofi Company2trials
Medical University Innsbruck2trials